Procept Biorobotics Corp Stock Performance
| PRCT Stock | USD 29.14 0.18 0.62% |
The company holds a Beta of 0.85, which implies possible diversification benefits within a given portfolio. Procept Biorobotics returns are very sensitive to returns on the market. As the market goes up or down, Procept Biorobotics is expected to follow. At this point, Procept Biorobotics Corp has a negative expected return of -0.0845%. Please make sure to check Procept Biorobotics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Procept Biorobotics Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Procept Biorobotics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Procept Biorobotics is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return 0.62 | Five Day Return (5.48) | Year To Date Return (5.27) | Ten Year Return (30.52) | All Time Return (30.52) |
1 | Truist Securities Adjusts Price Target on PROCEPT BioRobotics to 47 From 50, Maintains Buy Rating - marketscreener.com | 12/18/2025 |
2 | How Investors Are Reacting To PROCEPT BioRobotics UBS Coverage Initiation And 2027 Profitability Outlook | 12/24/2025 |
3 | ISRG Trading 4 percent Below All-Time High Should You Buy the Stock Now | 01/07/2026 |
4 | Is Wall Streets Split View On PROCEPT BioRobotics Revealing Aquablations True Strategic Position | 01/09/2026 |
5 | FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 42.10 percent - GuruFocus | 01/14/2026 |
6 | A Look At PROCEPT BioRobotics Valuation As Regulatory And Clinical Catalysts Draw Investor Focus | 01/23/2026 |
| Begin Period Cash Flow | 260.3 M | |
| Total Cashflows From Investing Activities | -4.4 M | |
| Free Cash Flow | -103.6 M |
Procept Biorobotics Relative Risk vs. Return Landscape
If you would invest 3,161 in Procept Biorobotics Corp on November 5, 2025 and sell it today you would lose (265.00) from holding Procept Biorobotics Corp or give up 8.38% of portfolio value over 90 days. Procept Biorobotics Corp is currently does not generate positive expected returns and assumes 3.5753% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Procept, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Procept Biorobotics Target Price Odds to finish over Current Price
The tendency of Procept Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 29.14 | 90 days | 29.14 | about 90.31 |
Based on a normal probability distribution, the odds of Procept Biorobotics to move above the current price in 90 days from now is about 90.31 (This Procept Biorobotics Corp probability density function shows the probability of Procept Stock to fall within a particular range of prices over 90 days) .
Procept Biorobotics Price Density |
| Price |
Predictive Modules for Procept Biorobotics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Procept Biorobotics Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Procept Biorobotics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Procept Biorobotics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Procept Biorobotics is not an exception. The market had few large corrections towards the Procept Biorobotics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Procept Biorobotics Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Procept Biorobotics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.33 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 2.37 | |
Ir | Information ratio | -0.09 |
Procept Biorobotics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Procept Biorobotics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Procept Biorobotics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Procept Biorobotics generated a negative expected return over the last 90 days | |
| Procept Biorobotics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 224.5 M. Net Loss for the year was (91.41 M) with profit before overhead, payroll, taxes, and interest of 193.58 M. | |
| Procept Biorobotics Corp currently holds about 269.81 M in cash with (99.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: A Look At PROCEPT BioRobotics Valuation As Regulatory And Clinical Catalysts Draw Investor Focus |
Procept Biorobotics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Procept Stock often depends not only on the future outlook of the current and potential Procept Biorobotics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Procept Biorobotics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.1 M | |
| Cash And Short Term Investments | 333.7 M |
Procept Biorobotics Fundamentals Growth
Procept Stock prices reflect investors' perceptions of the future prospects and financial health of Procept Biorobotics, and Procept Biorobotics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Procept Stock performance.
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 1.41 B | ||||
| Shares Outstanding | 55.88 M | ||||
| Price To Book | 4.28 X | ||||
| Price To Sales | 5.40 X | ||||
| Revenue | 224.5 M | ||||
| Gross Profit | 193.58 M | ||||
| EBITDA | (82 M) | ||||
| Net Income | (91.41 M) | ||||
| Cash And Equivalents | 269.81 M | ||||
| Cash Per Share | 6.05 X | ||||
| Total Debt | 80.25 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 16.01 X | ||||
| Book Value Per Share | 6.81 X | ||||
| Cash Flow From Operations | (99.21 M) | ||||
| Earnings Per Share | (1.52) X | ||||
| Market Capitalization | 1.62 B | ||||
| Total Asset | 534.02 M | ||||
| Retained Earnings | (545.99 M) | ||||
| Working Capital | 428.71 M | ||||
About Procept Biorobotics Performance
Assessing Procept Biorobotics' fundamental ratios provides investors with valuable insights into Procept Biorobotics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Procept Biorobotics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 269.76 | 292.80 | |
| Return On Tangible Assets | (0.15) | (0.16) | |
| Return On Capital Employed | (0.18) | (0.19) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.20) | (0.21) |
Things to note about Procept Biorobotics Corp performance evaluation
Checking the ongoing alerts about Procept Biorobotics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Procept Biorobotics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Procept Biorobotics generated a negative expected return over the last 90 days | |
| Procept Biorobotics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 224.5 M. Net Loss for the year was (91.41 M) with profit before overhead, payroll, taxes, and interest of 193.58 M. | |
| Procept Biorobotics Corp currently holds about 269.81 M in cash with (99.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05. | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: A Look At PROCEPT BioRobotics Valuation As Regulatory And Clinical Catalysts Draw Investor Focus |
- Analyzing Procept Biorobotics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Procept Biorobotics' stock is overvalued or undervalued compared to its peers.
- Examining Procept Biorobotics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Procept Biorobotics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Procept Biorobotics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Procept Biorobotics' stock. These opinions can provide insight into Procept Biorobotics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.